Treatment Trials

3 Clinical Trials for Various Conditions

Focus your search

COMPLETED
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
Description

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

COMPLETED
Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines
Description

To evaluate the safety and efficacy of EB-001 compared to placebo in subjects with glabellar frown lines (GL).

COMPLETED
AI-09 In Subjects With Glabellar Lines, GL-101
Description

AI-09 In Subjects with Glabellar Lines